LEVODOPA PEAK RESPONSE-TIME REFLECTS SEVERITY OF DOPAMINE NEURON LOSS IN PARKINSONS-DISEASE

被引:33
作者
SOHN, YH [1 ]
METMAN, LV [1 ]
BRAVI, D [1 ]
LINFANTE, I [1 ]
AOTSUKA, A [1 ]
MOURADIAN, MM [1 ]
CHASE, TN [1 ]
机构
[1] NINCDS,EXPTL THERAPEUT BRANCH,BETHESDA,MD 20892
关键词
D O I
10.1212/WNL.44.4.755
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We measured the time to peak antiparkinson response following injection of levodopa or apomorphine in 57 patients with Parkinson's disease. The peak response time for levodopa fell from 53 +/- 6.5 minutes in patients at Hoehn and Yahr stage I-II, and 28 +/- 4.8 minutes in those at stage TV (p < 0.0005). There was a significant correlation between levodopa peak response time and symptom duration (r = 0.65; p < 0.0001), but there was no relation between apomorphine peak response time and measures of disease severity. Peak response time to levodopa appears to reflect predominantly the status of compensatory presynaptic dopaminergic mechanisms and thus may provide an index to the degree of dopamine neuron degeneration in parkinsonian patients.
引用
收藏
页码:755 / 757
页数:3
相关论文
共 10 条
[1]   HYPERACTIVITY OF REMAINING DOPAMINERGIC NEURONS AFTER PARTIAL DESTRUCTION OF NIGRO-STRIATAL DOPAMINERGIC SYSTEM IN RAT [J].
AGID, Y ;
JAVOY, F ;
GLOWINSKI, J .
NATURE-NEW BIOLOGY, 1973, 245 (144) :150-151
[2]  
BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
[3]   RESPONSE TO A STANDARD ORAL LEVODOPA TEST IN PARKINSONIAN-PATIENTS WITH AND WITHOUT MOTOR FLUCTUATIONS [J].
CONTIN, M ;
RIVA, R ;
MARTINELLI, P ;
PROCACCIANTI, G ;
CORTELLI, P ;
AVONI, P ;
BARUZZI, A .
CLINICAL NEUROPHARMACOLOGY, 1990, 13 (01) :19-28
[4]   ACUTE EFFECTS OF PULSATILE LEVODOPA ADMINISTRATION ON CENTRAL DOPAMINE PHARMACODYNAMICS [J].
DAVIS, TL ;
BRUGHITTA, G ;
BARONTI, F ;
MOURADIAN, MM .
NEUROLOGY, 1991, 41 (05) :630-633
[5]   PERIPHERAL PHARMACOKINETICS OF LEVODOPA IN UNTREATED, STABLE, AND FLUCTUATING PARKINSONIAN-PATIENTS [J].
GANCHER, ST ;
NUTT, JG ;
WOODWARD, WR .
NEUROLOGY, 1987, 37 (06) :940-944
[6]   NONAMINERGIC STRIATAL NEURONS CONVERT EXOGENOUS L-DOPA TO DOPAMINE IN PARKINSONISM [J].
MELAMED, E ;
HEFTI, F ;
WURTMAN, RJ .
ANNALS OF NEUROLOGY, 1980, 8 (06) :558-563
[7]   MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE - CENTRAL PATHOPHYSIOLOGICAL MECHANISMS .2. [J].
MOURADIAN, MM ;
JUNCOS, JL ;
FABBRINI, G ;
SCHLEGEL, J ;
BARTKO, JJ ;
CHASE, TN .
ANNALS OF NEUROLOGY, 1988, 24 (03) :372-378
[8]   EFFECT OF LONG-TERM THERAPY ON THE PHARMACODYNAMICS OF LEVODOPA - RELATION TO ON-OFF PHENOMENON [J].
NUTT, JG ;
WOODWARD, WR ;
CARTER, JH ;
GANCHER, ST .
ARCHIVES OF NEUROLOGY, 1992, 49 (11) :1123-1130
[9]   ALTERED PHARMACOKINETICS OF L-DOPA METABOLISM IN RAT STRIATUM DEPRIVED OF DOPAMINERGIC INNERVATION [J].
SPENCER, SE ;
WOOTEN, GF .
NEUROLOGY, 1984, 34 (08) :1105-1108
[10]  
WOOTEN GF, 1987, MOVEMENT DISORD, V2, P231